A1 Refereed original research article in a scientific journal

Enhancing pediatric robotic pyeloplasty with a no-touch urothelium approach: a case series




AuthorsPakkasjärvi, Niklas; Jaakkola, Pyry; Ripatti, Liisi; Taskinen, Seppo

PublisherSpringer Science and Business Media LLC

Publishing placeLONDON

Publication year2025

JournalBMC Urology

Journal name in sourceBMC Urology

Journal acronymBMC UROL

Article number94

Volume25

Issue1

Number of pages4

eISSN1471-2490

DOIhttps://doi.org/10.1186/s12894-025-01782-y(external)

Web address https://doi.org/10.1186/s12894-025-01782-y(external)

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/491888694(external)


Abstract

Background: Robotic-assisted laparoscopic surgery has advanced minimally invasive urology. However, the absence of haptic feedback may increase the risk of tissue trauma. This case series evaluates a no-touch technique in robotic-assisted pyeloplasty to minimize urothelial handling and assess its feasibility and short-term outcomes.

Methods: This retrospective case series reviewed 20 pediatric patients with ureteropelvic junction obstruction treated with robotic-assisted pyeloplasty between 2019 and 2022. In 10 cases, a no-touch urothelium approach was applied to minimize direct tissue handling. Patient selection, surgical details, perioperative outcomes, and follow-up at 6 and 12 months were documented.

Results: The no-touch approach was successfully implemented in all cases without intraoperative complications. Median console time was 98 min (IQR: 81-131). Postoperative outcomes were favorable, with significant improvement or resolution of hydronephrosis in all cases. No major complications occurred, and no anastomotic strictures were observed during follow-up.

Conclusions: The no-touch technique in robotic-assisted pyeloplasty is a feasible approach that maintains surgical efficiency while minimizing direct urothelial handling. Further studies with larger sample sizes and longer follow-up are needed to validate its potential benefits.

Trial registration: This study was approved by the Institutional Review Board of New Children's Hospital, Helsinki University Hospital (permit nr 5485), Finland.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital).

No funding was received for this study.


Last updated on 2025-02-06 at 16:01